Recommended 17p takeover: what’s on the table and by when
Post period, essensys announced a recommended cash offer of 17 pence per share from a newly formed vehicle backed by Founder Mark Furness and a concert party. The Independent Directors consider the offer fair and reasonable, highlighting better access to capital and the removal of public company costs. The latest time for the offer to become or be declared unconditional is 5.00 p.m. on 8 May 2026.
For shareholders, this is a clean, certain exit at a disclosed level. The offer represents a c.9.7% premium to the closing share price on 27 November 2025, the day before the offer period began. Whether that feels full will depend on your view of the growth potential versus execution and funding risks set out in the half-year update.
Half-year 2026 headline numbers: revenue down, margins up, EBITDA just positive
essensys reported a 25% revenue decline to £7.8 million for the six months to 31 January 2026, mainly due to the continued downsizing of a single large strategic customer, portfolio rationalisation by customers, and churn in smaller and legacy Cloud accounts. Recurring revenue fell 24% to £7.0 million, with Run Rate Annual Recurring Revenue (ARR) down 24% to £12.7 million. At constant currency, revenue was £8.0 million (-23%) and Run Rate ARR £13.0 million (-22%).
Despite the top-line pressure, gross margin improved to 63% (H1 25: 59%) on a richer software mix and data centre decommissioning benefits. Adjusted EBITDA remained positive at £0.1 million (H1 25: £0.8 million), reflecting a simplified operational structure and lower operating expenses.
| Metric | H1 26 | H1 25 | Change |
|---|---|---|---|
| Revenue | £7.8m | £10.4m | -25% |
| Recurring revenue | £7.0m | £9.2m | -24% |
| Run Rate ARR | £12.7m | £16.8m | -24% |
| Gross profit | £5.0m | £6.1m | -18% |
| Gross margin | 63% | 59% | +4pp |
| Adjusted EBITDA | £0.1m | £0.8m | n/a |
| Statutory loss before tax | (£1.7m) | (£1.8m) | n/a |
| Loss per share | (2.58)p | (3.00)p | n/a |
| Net cash | £0.9m | £2.2m | n/a |
| Recurring revenue as % of total | 89.0% | 88.4% | +0.6pp |
Why revenue fell: concentration and portfolio pruning
The decline was led by the continued downsizing of one large North American customer and the loss of a large UK customer at the end of December, which represented £0.9 million of ARR. Broader industry caution is still evident, with landlords and operators rationalising portfolios and slowing capital spend, which also weighed on non-recurring installation revenue (-29%).
On an underlying basis, there are some stabilisers: excluding the downsized North American customer and the lost UK customer and at constant currency, Run Rate ARR decreased by 12%. ARR from strategic customers fell 6% on the same basis and still represents 73% of total ARR (H1 25: 74%), underscoring both the importance and the concentration risk of larger accounts.
Cash, debt and going concern: the crux of risk
essensys closed the half with £0.9 million of cash and remains debt free. Discussions are ongoing to secure a debt facility, and cash management is a stated priority. Reported cash outflow in H1 26 was £1.3 million (H1 25: £0.9 million), with the prior period benefiting from £0.9 million of R&D tax credits. On that basis, underlying cash outflows improved by £0.5 million year on year.
The board flags material uncertainties over going concern. The later-than-expected timing of the offer has reduced cash headroom, and while potential backstops exist (debt financing discussions, equity funding or other shareholder support), none are guaranteed. The Independent Directors have not pursued further cost efficiency actions while the offer remains in progress.
Plain English version: funding clarity is needed soon. The recommended offer, if declared unconditional, would address this by removing PLC costs and providing access to capital. If it does not complete, alternative funding will be required.
Product and partnerships: elumo live, OfficeRnD tie-up
The business has been reshaped around two core products: the essensys Platform (enterprise-grade Wi-Fi across multi-tenant portfolios with data insights) and elumo (bookings and access to monetise meeting rooms and shared spaces). The first cohort of elumo sites is live. Sales cycles are elongated and adoption slower in the current environment, but customer interest is described as strong.
The OfficeRnD partnership should help embed essensys deeper into customers’ operating stacks, supporting retention and accelerating sales cycles across both products. On the tech side, elumo now includes wireless access solutions (wireless handles and locks) to simplify deployment and speed roll-outs. The data centre decommissioning programme continues to lower cost-to-serve, with another site closed in January and one more expected in H2.
Regional trends: North America hit, APAC expanding
North America remains the largest contributor but fell 36% to £3.7 million, mainly due to the single strategic customer downsizing. Excluding that customer and at constant currency, North American Run Rate ARR decreased by 14%, and the region still accounts for 52% of total ARR (H1 25: 50%).
UK & Europe revenue declined 18% to £3.1 million, reflecting the loss of the large UK customer and softer demand for the Operate solution. APAC continues to grow from a smaller base: revenue rose 24% to £1.0 million, with 17 new sites live versus this time last year, a 52% increase.
Jargon buster
- ARR (Annual Recurring Revenue): a snapshot of the annualised value of monthly recurring revenue at a point in time.
- Adjusted EBITDA: earnings before interest, tax, depreciation and amortisation, adjusted for items like share-based payments and exceptional costs.
- Recurring vs non-recurring revenue: ongoing subscription-like income versus one-off installation and set-up fees.
- Going concern: an accounting assessment of whether a company can continue to operate for at least 12 months from approval of the accounts. “Material uncertainties” flag meaningful risk to that assumption.
My take for investors: the balance of upside and risk
Positives
- Recommended 17p cash offer provides certainty of value and a near-term timeline (latest 8 May 2026).
- Margins are moving the right way: gross margin 63% and recurring margin 65%, helped by mix shift and infrastructure savings.
- Adjusted EBITDA remains positive despite a tough top line; operating expenses fell 8%.
- Clear product focus, with first elumo sites live and a credible go-to-market boost via OfficeRnD.
- APAC momentum, with site growth and higher regional revenue.
Watch-outs
- Funding risk: £0.9 million cash and material going concern uncertainties until the offer completes or alternative funding is secured.
- Revenue headwinds: Run Rate ARR down 24% and elongated sales cycles; underlying ARR ex two customers still fell 12% at constant currency.
- Customer concentration: strategic accounts represent 73% of ARR – great when expanding, painful when downsizing.
- Management change: the CFO has resigned and will depart after an April handover.
Bottom line
essensys is executing a sensible refocus on its core platform and elumo, improving support quality and margins. But the macro drag, key account downsizing and low cash balance leave the equity story intertwined with the 17p offer and near-term funding clarity. If you want certainty, the recommended cash exit is straightforward. If you see medium-term product upside, you are taking on execution and financing risk flagged plainly by the board.
Near-term catalyst: the offer’s latest unconditional date is 5.00 p.m. on 8 May 2026. Until then, all eyes are on cash, churn and any sign of an improving sales cadence.
